In agreement with these observations, a complete or partial loss of MIG-6 expression has been observed in various human malignancies, including carcinomas of the breast, thyroid gland, liver and lungs, as well as in endometrial cancer and glioblastoma [25]. The gene discussed is ERRFI1; the disease is endometrial cancer.